La vendita allo scoperto per Oversea-Chinese Banking dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Oversea-Chinese Banking. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Oversea-Chinese Banking (OTC:OVCHY) Azioni, Report sulle vendite allo scoperto

OVERSEA-CHINESE ADR

Oversea-Chinese Banking

Oversea-Chinese Banking Corp. is the longest-established Singapore bank, founded by the merger of three local banks in 1932. OCBC's operations include consumer banking; wealth management and private banking (through its Bank of Singapore subsidiary); small to midsize enterprise and business banking; corporate and institutional banking; and insurance through majority-owned Great Eastern.

OVERSEAS CHINSE UNSP/ADR by Overseas Chinese Banking Corp., Ltd.

Oversea-Chinese Banking Corp Ltd

<a href="https://register.epo.org/application?number=EP21788894" title="https://register.epo.org/application?number=EP21788894">https://register.epo.org/application?number=EP21788894</a>

Biotech

News

General

AEMD

Aethlon Medical Has Been Granted European Patent Number EP4136453 Titled "LECTIN FOR USE IN METHODS FOR TREATING A SEQUELA OF CORONAVIRUS INFECTION"

Truist Securities analyst Ki Bin Kim maintains Macerich (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) with a Buy and raises the price target from $19 to $21.

Price Target

Analyst Ratings

Truist Securities Maintains Buy on Macerich, Raises Price Target to $21

<a href="https://www.apple.com/apple-events/event-stream/?useASL=true" title="https://www.apple.com/apple-events/event-stream/?useASL=true">https://www.apple.com/apple-events/event-stream/?useASL=true</a>

Events

AAPL

Apple Highlights New Calling Features In iOS 26, With 'Hold Assist'

Raymond James analyst Bobby Griffin initiates coverage on Arhaus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARHS#NASDAQ">ARHS</a>) with a Market Perform rating.

Initiation

ARHS

Raymond James Initiates Coverage On Arhaus with Market Perform Rating

Barclays analyst Brian Morton maintains Toronto-Dominion Bank (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TD#TSX">TD</a>) with a Underweight and raises the price target from C$83 to C$91.

TSX:TD

Barclays Maintains Underweight on Toronto-Dominion Bank, Raises Price Target to C$91

Piper Sandler analyst Jessica Tassan maintains Oscar Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>) with a Overweight and lowers the price target from $25 to $18.

OSCR

Piper Sandler Maintains Overweight on Oscar Health, Lowers Price Target to $18

<a href="https://www.reuters.com/business/healthcare-pharmaceuticals/unitedhealth-eyes-1-billion-deal-exit-latin-america-insurer-refocuses-us-sources-2025-06-09/#:~:text=UnitedHealth%20left%20Brazil%20in%202023,proposals%20as%20soon%20as%20July" title="https://www.reuters.com/business/healthcare-pharmaceuticals/unitedhealth-eyes-1-billion-deal-exit-latin-america-insurer-refocuses-us-sources-2025-06-09/#:~:text=UnitedHealth%20left%20Brazil%20in%202023,proposals%20as%20soon%20as%20July">https://www.reuters.com/business/healthcare-pharmaceuticals/unitedhealth-eyes-1-billion-deal-exit-latin-america-insurer-refocuses-us-sources-2025-06-09/#:~:text=UnitedHealth%20left%20Brazil%20in%202023,proposals%20as%20soon%20as%20July</a>.

Reported Earlier: 'UnitedHealth Eyes $1 Billion Deal To Exit Latin America As Insurer Refocuses On US, Sources Say' - Reuters News

Piper Sandler analyst Mark Lear initiates coverage on Crescent Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRGY#NYSE">CRGY</a>) with a Overweight rating and announces Price Target of $14.

CRGY

Piper Sandler Initiates Coverage On Crescent Energy with Overweight Rating, Announces Price Target of $14

Apple Highlights iOS 26 CarPlay Features

Apple Highlights Redesigned Facetime Page

The J. M. Smucker Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SJM#NYSE">SJM</a>) will release its fourth-quarter earnings results before the opening <a href="https://www.benzinga.com/quote/SJM/earnings">bell on Tuesday, June 10.</a>
Analysts expect the Orrville, Ohio-based company to report quarterly earnings at $2.25 per share, down from $2.66 per share in the year-ago period. J. M. Smucker projects to report quarterly revenue at $2.19 billion, compared to $2.21 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On April 30, JM Smucker named John Brase as President and COO.
JM Smucker shares gained 0.5% to trade at $111.45 on Monday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/SJM/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Morgan Stanley analyst Megan Alexander maintained an Overweight rating and raised the price target from $123 to $124 on June 6, 2025. This analyst has an accuracy rate of 69%.</li>
<li>Stifel analyst Matthew Smith maintained a Hold rating and cut the price target from $125 to $120 on Jan. 24, 2025. This analyst has an accuracy rate of 60%.</li>
<li>TD Cowen analyst Robert Moskow downgraded the stock from Buy to Hold and cut the price target from $130 to $121 on Jan. 8, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Wells Fargo analyst Chris Carey maintained an Overweight rating and raised the price target from $130 to $135 on Nov. 27, 2024. This analyst has an accuracy rate of 62%.</li>
</ul>
Considering buying SJM stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/SJM/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="592" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09125530/image-123-1024x592.png" alt="" class="wp-image-943585" style="width:650px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09125530/image-123-1024x592.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09125530/image-123-300x174.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09125530/image-123-768x444.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09125530/image-123.png 1103w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/06/45835438/top-3-financial-stocks-that-may-collapse-in-june">Top 3 Financial Stocks That May Collapse In June</a> </li>
</ul>
Photo via Shutterstock

Earnings

Markets

Trading Ideas

JM Smucker Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Options

PTON

Peloton Interactive Option Alert: Oct 17 $8 Calls at the Ask: 4000 @ $1.51 vs 11077 OI; Ref=$7.815

G-III Apparel Group, LTD. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIII#NASDAQ">GIII</a>) posted better-than-expected earnings for its <a href="https://www.benzinga.com/quote/GIII/earnings">first quarter on Friday</a>.
The company reported first-quarter adjusted earnings per share of 19 cents, beating the analyst consensus estimate of 12 cents. Quarterly sales of $583.61 million (down 4% year over year), outpacing the Street view of $580.37 million.
"Our performance was fueled by double-digit growth of our key owned brands, DKNY, Karl Lagerfeld and Donna Karan, which largely offset the exit of the Calvin Klein jeans and sportswear businesses," said CEO Morris Goldfarb.
Due to tariff and macro uncertainty, G-III Apparel withdraws FY26 profit guidance and sees a $135 million unmitigated tariff hit, mostly in the second half. G-III Apparel Group affirms FY2026 sales guidance of $3.14 billion vs $3.12 billion estimate.
As previously planned, the company continues to expect sales to be lower in the first half of fiscal 2026 than in the previous year, with acceleration expected in the second half of fiscal 2026.
G-III Apparel Group expects second-quarter EPS of $0.02–$0.12 and revenue of approximately $570 million versus the $621 million estimate.
G-III Apparel shares fell 2.7% to trade at $21.90 on Monday.
These analysts made changes to their price targets on G-III Apparel following earnings announcement.
<ul class="wp-block-list">
<li>Telsey Advisory Group analyst Dana Telsey maintained G-III Apparel with a Market Perform and lowered the price target from $30 to $27.</li>
<li>Keybanc analyst Ashley Owens maintained the stock with an Overweight rating and lowered the price target from $40 to $30.</li>
<li>Barclays analyst Paul Kearney maintained G-III Apparel with an Underweight rating and cut the price target from $21 to $18.</li>
</ul>
Considering buying GIII stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/giii/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="593" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09131538/image-125-1024x593.png" alt="" class="wp-image-943619" style="width:629px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09131538/image-125-1024x593.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09131538/image-125-300x174.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09131538/image-125-768x445.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/09131538/image-125.png 1088w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/06/45841411/oracle-to-rally-around-15-here-are-10-top-analyst-forecasts-for-monday">Oracle To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Monday</a> </li>
</ul>
Photo via Shutterstock

GIII

G-III Apparel Analysts Slash Their Forecasts After Q1 Results

Barclays analyst Brian Morton maintains Royal Bank of Canada (TSX:<a class="ticker" href="https://www.benzinga.com/stock/RY#TSX">RY</a>) with a Overweight and raises the price target from C$180 to C$182.

TSX:RY

Barclays Maintains Overweight on Royal Bank of Canada, Raises Price Target to C$182

WIIM

TTGT

TechTarget shares are trading higher after Craig-Hallum reinstated its Buy rating on the stock  and announced a $12 price target.

Apple Says iOS 26 Is 'More Intuitive'

Barclays analyst Adrienne Yih maintains PVH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) with a Overweight and lowers the price target from $87 to $83.

Barclays Maintains Overweight on PVH, Lowers Price Target to $83

Barclays analyst Andrew Mok maintains Molina Healthcare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>) with a Equal-Weight and lowers the price target from $351 to $347.

Comments

Oversea-Chinese Banking

Vendite allo scoperto

Oversea-Chinese Banking (OTC:OVCHY) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO